Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. | Int J Mol Sci | 2023 | 37628906 | PubTator, text mining | PubMed |
| Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients. | Biomedicines | 2023 | 37626782 | PubTator, text mining | PubMed |
| Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms. | Sci Rep | 2023 | 37620619 | PubTator, text mining | PubMed |
| p53-dependent R-loop formation and HPV pathogenesis. | Proc Natl Acad Sci U S A | 2023 | 37611058 | PubTator, text mining | PubMed |
| Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancer. | Prostate | 2023 | 37583103 | PubTator, text mining | PubMed |
| Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes. | Int J Mol Sci | 2023 | 37569386 | PubTator, text mining | PubMed |
| Flipons and small RNAs accentuate the asymmetries of pervasive transcription by the reset and sequence-specific microcoding of promoter conformation. | J Biol Chem | 2023 | 37544644 | PubTator, text mining | PubMed |
| Selective DNA-binding of SP120 (rat ortholog of human hnRNP U) is mediated by arginine-glycine rich domain and modulated by RNA. | PLoS One | 2023 | 37540655 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures. | Front Oncol | 2023 | 37534254 | PubTator, text mining | PubMed |
| EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. | Redox Biol | 2023 | 37531930 | PubTator, text mining | PubMed |
| DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost. | Sci Rep | 2023 | 37528151 | PubTator, text mining | PubMed |
| Screening of Phyllanthus niruri Root Phytoconstituents for Antibacterial, Antifungal, Anticancer, and Antiviral Activities by Molecular Docking Studies. | Adv Exp Med Biol | 2023 | 37525038 | PubTator, text mining | PubMed |
| Screening of Phyllanthus niruri Leaves Phytoconstituents for Antiviral and Antibacterial Activity by Molecular Docking Studies. | Adv Exp Med Biol | 2023 | 37525036 | PubTator, text mining | PubMed |
| Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire. | Biomedicines | 2023 | 37509723 | PubTator, text mining | PubMed |
| Lactate Can Modulate the Antineoplastic Effects of Doxorubicin and Relieve the Drug's Oxidative Damage on Cardiomyocytes. | Cancers (Basel) | 2023 | 37509389 | PubTator, text mining | PubMed |
| Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs. | Antioxidants (Basel) | 2023 | 37507917 | PubTator, text mining | PubMed |
| Proliferating cell nuclear antigen inhibitors block distinct stages of herpes simplex virus infection. | PLoS Pathog | 2023 | 37486931 | PubTator, text mining | PubMed |
| Abnormal phase separation of biomacromolecules in human diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37475546 | PubTator, text mining | PubMed |
| The topoisomerase II β -kinase associated with HIV-1 is a potential target for pyridine-bischalcones' anti-HIV-1 activity. | Eur J Med Chem | 2023 | 37473689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=11